Gilpin Wealth Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$340K Buy
2,283
+2
+0.1% +$281 0.23% 99
2026
Q2
$288K Hold
2,281
– – 0.2% 106
2026
Q1
$318K Hold
2,281
– – 0.25% 90
2025
Q4
$280K Buy
+2,281
New +$277K 0.22% 94

Other funds holding GILD

Gilpin Wealth Management's GILD Position: Q3 2026 in Review

Gilpin Wealth Management increased its Gilead Sciences (GILD) stake by 0.09% in Q3 2026, buying an estimated $281 and bringing the position to 2,283 shares worth $340K. The position accounts for 0.23% of the portfolio, ranked #99.

Gilpin Wealth Management first reported a position in GILD in Q4 2025 and has held it in 4 quarters since. 119 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • Gilpin Wealth Management held 2,283 shares of Gilead Sciences worth $340K as of Q3 2026.
  • Gilpin Wealth Management bought 2 Gilead Sciences shares in Q3 2026, an estimated $281.
  • Gilead Sciences made up 0.23% of Gilpin Wealth Management's portfolio in Q3 2026, its #99 holding.
  • Gilpin Wealth Management first reported a position in Gilead Sciences in Q4 2025 and has held it in 4 quarters since.
  • 119 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Gilpin Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.